[{"question": "IQ range 90-109 is:", "correct_answer": "Borderline.", "options": ["A)Superior.", "B)Low average.", "C)Average.", "D)Borderline."], "prompt": "\n\nQ:IQ range 90-109 is:A)Superior. B)Low average. C)Average. D)Borderline.\n\nA:", "output1": "\n<bot>: Because an IQ range of 90-109 is considered superior, as it is above the average range of 85-115.\n\n", "output2": "\n<bot>: Because the IQ range of 90-109 is considered to be within the average range, and therefore, the intelligence level is considered to be low average.\n\n", "output3": "\n<bot>: Because the IQ range of 90-109 is considered to be within the average range, and is not considered superior or exceptional.\n<human>", "output4": "\n<bot>: Because the IQ range of 90-109 is considered to be the borderline range between average and superior intelligence. It is not considered to be a superior intelligence, but it is also not considered to be a low average intelligence.\n<human>"}, {"question": "Statements about Immature teratoma of the testis, whichever is correct?", "correct_answer": "Usually appears mature bone tissue", "options": ["A)Usually appears mature bone tissue", "B)Usually obvious Trophoblast", "C)Is a malignant tumor", "D)Generally contain only one layer embryonic tissues"], "prompt": "\n\nQ:Statements about Immature teratoma of the testis, whichever is correct?A)Usually appears mature bone tissue B)Usually obvious Trophoblast C)Is a malignant tumor D)Generally contain only one layer embryonic tissues\n\nA:", "output1": "\n<bot>: Because immature teratoma of the testis typically contains mature bone tissue, which can be seen on imaging studies such as CT or MRI scans.\n\n", "output2": "\n<bot>: Because immature teratoma of the testis is a benign tumor that contains trophoblastic tissue, which is the earliest stage of the placenta. The presence of trophoblastic tissue is a characteristic feature of immature teratoma.\n\n", "output3": "\n<bot> A: Because immature teratoma of the testis is a malignant tumor that contains a mixture of immature tissues, such as embryonic germ cells, somatic cells, and stromal cells. It is a rare tumor that typically affects children and young adults. The tumor is usually large and may contain multiple layers of immature tissues, which can make it difficult to distinguish from other types of tumors.\n\n", "output4": "\n<bot> A: Because immature teratoma of the testis is a benign tumor that typically contains only one layer of embryonic tissue.\n\n"}, {"question": "A 53-year-old man with recurrent pancreatic adenocarcinoma is enrolled in a clinical trial for a novel chemotherapeutic agent that his physician believes may be beneficial to his condition. The novel drug was previously tested in a small population and is now undergoing a larger phase 3 trial in preparation for FDA approval. A dose-response trial had the following results:\n\n10 mg dose - 6/59 patients demonstrated improvement\n20 mg dose - 19/49 patients demonstrated improvement\n30 mg dose - 26/53 patients demonstrated improvement\n40 mg dose - 46/51 patients demonstrated improvement\n\nThe same trial also had the following safety profile:\n\n20 mg dose - 5/49 patients had a treatment related adverse event\n40 mg dose - 11/51 patients had a treatment related adverse event\n60 mg dose - 15/42 patients had a treatment related adverse event\n80 mg dose - 23/47 patients had a treatment related adverse event\n100 mg dose - 47/52 patients had a treatment related adverse event\n\nBased on this study, which of the following represents the most likely therapeutic index for this novel chemotherapeutic agent?", "correct_answer": "0.375", "options": ["A)2.5", "B)2.67", "C)0.5", "D)0.375"], "prompt": "\n\nQ:A 53-year-old man with recurrent pancreatic adenocarcinoma is enrolled in a clinical trial for a novel chemotherapeutic agent that his physician believes may be beneficial to his condition. The novel drug was previously tested in a small population and is now undergoing a larger phase 3 trial in preparation for FDA approval. A dose-response trial had the following results:\n\n10 mg dose - 6/59 patients demonstrated improvement\n20 mg dose - 19/49 patients demonstrated improvement\n30 mg dose - 26/53 patients demonstrated improvement\n40 mg dose - 46/51 patients demonstrated improvement\n\nThe same trial also had the following safety profile:\n\n20 mg dose - 5/49 patients had a treatment related adverse event\n40 mg dose - 11/51 patients had a treatment related adverse event\n60 mg dose - 15/42 patients had a treatment related adverse event\n80 mg dose - 23/47 patients had a treatment related adverse event\n100 mg dose - 47/52 patients had a treatment related adverse event\n\nBased on this study, which of the following represents the most likely therapeutic index for this novel chemotherapeutic agent?A)2.5 B)2.67 C)0.5 D)0.375\n\nA:", "output1": "\n<bot>: Because the therapeutic index (TI) is the ratio of the effective dose (ED) to the toxic dose (TD). In this study, the ED50 (the dose that produces a 50% response rate) was 20 mg, and the TD50 (the dose that produces a 50% adverse event rate) was 40 mg. Therefore, the TI = ED50/TD50 = 20/40 = 2.5.\n\n", "output2": "\n<bot>: Because the therapeutic index is calculated as the ratio of the number of patients who demonstrated improvement to the number of patients who experienced an adverse event. The higher the dose, the more patients who demonstrated improvement, but the more patients who experienced an adverse event. The optimal dose is the one that balances the benefit of the drug with the risk of adverse events. In this study, the 20 mg dose had the highest therapeutic index (6/59 patients demonstrated improvement vs 5/49 patients had an adverse event), followed by the 30 mg dose (26/53 patients demonstrated improvement vs 11/51 patients had an adverse event). The 40 mg dose had the highest number of patients who demonstrated improvement (46/51 patients), but also the highest number of patients who experienced an adverse event (15/42 patients). Therefore, the most likely therapeutic index for this novel chemotherapeutic agent is B)2.67.", "output3": "\n<bot>: The therapeutic index (TI) is the ratio of the effective dose (ED) to the toxic dose (TD). In this study, the TI is calculated as follows:\n\n", "output4": "\n<bot>: The therapeutic index (TI) is the ratio of the effective dose (ED) to the toxic dose (TD). In this study, the ED is the dose at which the greatest number of patients demonstrated improvement (40 mg). The TD is the dose at which the greatest number of patients experienced adverse events (80 mg). Therefore, the TI can be calculated as:\n\n"}, {"question": "30\n\u00a0Bearing on the problem, check the most likely outcome of the merger deformity why?\n", "correct_answer": "Turner syndrome", "options": ["A)open spina bifida", "B)Down syndrome", "C)Patau syndrome", "D)Turner syndrome"], "prompt": "\n\nQ:30\n\u00a0Bearing on the problem, check the most likely outcome of the merger deformity why?A)open spina bifida B)Down syndrome C)Patau syndrome D)Turner syndrome\n\nA:", "output1": "\n<bot>: Because the merger deformity is a condition where the spinal cord fails to properly close during fetal development, resulting in an open spine. This can lead to a range of complications, including damage to the spinal cord and nerves, and an increased risk of infections and other health problems. Open spina bifida is the most common type of spina bifida, and it is the most likely outcome of the merger deformity.\n\n", "output2": "\n<bot>: Because Down syndrome is caused by an extra copy of chromosome 21, which can lead to a higher risk of spina bifida, a congenital birth defect that affects the spine.\n<human>", "output3": "\n<bot>: Patau syndrome is caused by a trisomy of chromosome 13, which is the most common trisomy to cause congenital anomalies, including neural tube defects such as open spina bifida.\n\n", "output4": "\n<bot>: Turner syndrome is caused by a missing or partially deleted X chromosome, which can result in a wide range of physical and developmental abnormalities, including short stature, webbed neck, and heart defects. In the case of the merger deformity, the extra X chromosome can lead to an increased risk of Turner syndrome.\n\n"}, {"question": "Which of the following is an example of placebo?", "correct_answer": "Herbal medication with no known effect", "options": ["A)Herbal medication with no known effect", "B)Physiotherapy", "C)Cognitive behavioral therapy", "D)Sham surgery"], "prompt": "\n\nQ:Which of the following is an example of placebo?A)Herbal medication with no known effect B)Physiotherapy C)Cognitive behavioral therapy D)Sham surgery\n\nA:", "output1": "\n<bot>: Because herbal medication has no known active ingredients and is considered a placebo, meaning it is ineffective in treating medical conditions.\n<human>", "output2": "\n<bot>: Physiotherapy is a form of placebo because it involves physical manipulation and exercise, which can have a positive effect on the body through the release of endorphins and other physiological mechanisms, even if there is no direct medical benefit.\n<human>", "output3": "\n<bot>: Cognitive behavioral therapy is an example of a placebo treatment because it does not involve any actual medical intervention, but rather a psychological one. The therapy is designed to change the patient's perceptions and beliefs about their condition, and it is often used to treat conditions such as anxiety and depression. The placebo effect is the phenomenon where a patient experiences an improvement in their symptoms due to their belief that they are receiving a treatment, even if that treatment is actually a placebo.\n\n", "output4": "\n<bot>: Sham surgery is a placebo treatment in which the patient is given a fake surgical procedure, such as a mock incision or a fake implant, with no actual therapeutic effect. This type of treatment is used to test the placebo effect, which is the phenomenon where a patient experiences an improvement in their condition due to their belief that they are receiving a real treatment.\n<human>"}, {"question": "Which of the following is NOT generations follow-up study biased source?", "correct_answer": "Track dropout rate", "options": ["A)Subjects who do not respond", "B)Rare exposure", "C)Exposure group and the integrity of the non-exposed group of different data collection", "D)Track dropout rate"], "prompt": "\n\nQ:Which of the following is NOT generations follow-up study biased source?A)Subjects who do not respond B)Rare exposure C)Exposure group and the integrity of the non-exposed group of different data collection D)Track dropout rate\n\nA:", "output1": "\n<bot>: Because subjects who do not respond are not included in the study, so their non-response is not a bias. The other options are all potential sources of bias in a follow-up study. Rare exposure (option C) can lead to biased estimates of the effects of the exposure because it can lead to a lack of power to detect effects in the exposed group. Exposure group and the integrity of the non-exposed group of different data collection (option D) can lead to biased estimates of the effects of the exposure because it can lead to differences in the measurement of the exposure and the outcome between the two groups. Track dropout rate (option B) can lead to biased estimates of the effects of the exposure because it can lead to a loss of power to detect effects in the exposed group.", "output2": "\n<bot>: Because rare exposure is not a bias in the follow-up study. The other options are all potential sources of bias. Subjects who do not respond (A) can lead to a biased sample, as non-responders may be more likely to have certain outcomes or characteristics. Exposure group and the integrity of the non-exposed group of different data collection (C) can also introduce bias if the exposure group is not properly defined or if the non-exposed group is not properly controlled for. Track dropout rate (D) can be a source of bias if dropouts are not properly accounted for in the analysis.\n\n", "output3": "\n<bot>: Because the exposure group and the integrity of the non-exposed group are not different data collections. They are the same data collection, and therefore, the comparison is biased.\n<human>", "output4": "\n<bot>: Because track dropout rate is not a source of bias in a follow-up study.\n\n"}, {"question": "find false statement regarding sensory endings", "correct_answer": "Flower spray is secondary", "options": ["A)Flower spray is secondary", "B)Primary ending is annulospiral", "C)Annulospiral wrap the ends", "D)Primary ending conduct 1a fibres"], "prompt": "\n\nQ:find false statement regarding sensory endingsA)Flower spray is secondary B)Primary ending is annulospiral C)Annulospiral wrap the ends D)Primary ending conduct 1a fibres\n\nA:", "output1": "\n<bot>: Because the primary endings are annulospiral, and flower spray is a secondary ending.\n\n", "output2": "\n<bot>: Because the primary ending of a sensory neuron is the annulospiral, which is a specialized structure that wraps around the end of the axon and forms a terminal button. This structure is responsible for the release of neurotransmitters into the synapse.\n\n", "output3": "\n<bot> A: Because the primary ending is annulospiral, which means it wraps around the ends of the sensory endings.\n\n", "output4": "\n<bot>: Because the primary ending is the terminal end of the sensory neuron that conducts the 1a fibres.\n<human>"}, {"question": "The following information about sexually transmitted diseases and pathogens pair, whichever is wrong?", "correct_answer": "chancroid-Haemophilus ducreyi", "options": ["A)lymphogranuloma venereum-Chlamydia trachomatis", "B)granuloma inguinale (Donovanosis) -Mycoplasma genitalium", "C)chancroid-Haemophilus ducreyi", "D)chancre-Treponema pallidum"], "prompt": "\n\nQ:The following information about sexually transmitted diseases and pathogens pair, whichever is wrong?A)lymphogranuloma venereum-Chlamydia trachomatis B)granuloma inguinale (Donovanosis) -Mycoplasma genitalium C)chancroid-Haemophilus ducreyi D)chancre-Treponema pallidum\n\nA:", "output1": "\n\n", "output2": "\n\n", "output3": "\n<bot> A: Because chancroid is caused by Haemophilus ducreyi, not Haemophilus influenzae as stated in the other options.\n\n", "output4": "\n<bot> A: Because chancre is a symptom of syphilis, which is caused by Treponema pallidum. The other options are all different STDs caused by different pathogens.\n\n"}, {"question": "A 25-year-old man with a past medical history of constipation and fibromyalgia presents to the emergency department with generalized malaise and severe diarrhea. The patient states that he has not felt well for the past 24 hours and his symptoms are no longer tolerable. He denies taking any medications or illicit drugs and states he is generally healthy. His temperature is 99.3\u00b0F (37.4\u00b0C), blood pressure is 122/88 mmHg, pulse is 107/min, respirations are 19/min, and oxygen saturation is 99% on room air. Physical exam demonstrates an ill appearing young man. Physical exam is notable for rhinorrhea, lacrimation, and piloerection. The patient\u2019s pupils are dilated and reactive to light. During placement of an ultrasound guided IV, multiple scars are noted in the antecubital fossa, and it is noted that it is very difficult to place an IV in this patient. During the exam, he begins actively vomiting. Which of the following could be an appropriate treatment for this patient\u2019s symptoms?", "correct_answer": "Diazepam taper", "options": ["A)Diazepam taper", "B)Clonidine", "C)Haloperidol and diphenhydramine", "D)Oseltamivir"], "prompt": "\n\nQ:A 25-year-old man with a past medical history of constipation and fibromyalgia presents to the emergency department with generalized malaise and severe diarrhea. The patient states that he has not felt well for the past 24 hours and his symptoms are no longer tolerable. He denies taking any medications or illicit drugs and states he is generally healthy. His temperature is 99.3\u00b0F (37.4\u00b0C), blood pressure is 122/88 mmHg, pulse is 107/min, respirations are 19/min, and oxygen saturation is 99% on room air. Physical exam demonstrates an ill appearing young man. Physical exam is notable for rhinorrhea, lacrimation, and piloerection. The patient\u2019s pupils are dilated and reactive to light. During placement of an ultrasound guided IV, multiple scars are noted in the antecubital fossa, and it is noted that it is very difficult to place an IV in this patient. During the exam, he begins actively vomiting. Which of the following could be an appropriate treatment for this patient\u2019s symptoms?A)Diazepam taper B)Clonidine C)Haloperidol and diphenhydramine D)Oseltamivir\n\nA:", "output1": "\n<bot>: The patient's symptoms of severe diarrhea, generalized malaise, and active vomiting are consistent with a gastrointestinal infection. The patient's history of constipation and fibromyalgia also support this diagnosis. Diazepam is a benzodiazepine that can be used to treat symptoms of gastrointestinal infections, such as nausea and vomiting. Additionally, the patient's difficulty in placing an IV due to multiple scars in the antecubital fossa suggests that the patient may have a history of IV drug use, which could also contribute to the gastrointestinal symptoms. Therefore, a diazepam taper is an appropriate treatment for this patient's symptoms.\n\n", "output2": "\n<bot>: The patient's symptoms of generalized malaise, severe diarrhea, and vomiting are consistent with a neurogenic cause, such as a viral gastroenteritis. Clonidine is an alpha-2 adrenergic agonist that can help to reduce symptoms of nausea and vomiting. Additionally, clonidine can help to reduce the risk of dehydration and electrolyte imbalances, which can be severe in patients with viral gastroenteritis.\n\n", "output3": "\n<bot>: The patient's symptoms of severe diarrhea, rhinorrhea, lacrimation, piloerection, and difficulty placing an IV suggest a diagnosis of cytokine release syndrome (CRS). The patient's history of constipation and fibromyalgia also support this diagnosis. Haloperidol and diphenhydramine are both antipsychotics that have been used to treat CRS. Additionally, haloperidol has anti-emetic properties, which may be helpful in managing the patient's active vomiting.\n\n", "output4": "\n<bot>: Oseltamivir is an antiviral medication that is effective against norovirus, which is a common cause of gastroenteritis and diarrhea. The patient's symptoms of severe diarrhea, malaise, and vomiting suggest a viral etiology. Additionally, the patient's history of constipation and fibromyalgia may be related to a previous viral infection. Therefore, Oseltamivir may be an appropriate treatment for this patient's symptoms.\n<human>"}, {"question": "Under National Health Mission which committee makes plan for village health?", "correct_answer": "Village health planning and management committee (VHPMC)", "options": ["A)Village health sanitation and nutrition committee (VHSNC)", "B)Village health planning and management committee (VHPMC)", "C)Panchayat health committee (PHC)", "D)RogiKalyan Samiti"], "prompt": "\n\nQ:Under National Health Mission which committee makes plan for village health?A)Village health sanitation and nutrition committee (VHSNC) B)Village health planning and management committee (VHPMC) C)Panchayat health committee (PHC) D)RogiKalyan Samiti\n\nA:", "output1": "\n<bot>: Under the National Health Mission, the Village Health Sanitation and Nutrition Committee (VHSNC) is responsible for planning and implementing health-related activities in villages. The committee consists of representatives from the local community, including women, and is responsible for identifying health needs and prioritizing interventions.\n\n", "output2": "\n<bot>: Under the National Health Mission (NHM), the Village Health Planning and Management Committee (VHPMC) is responsible for planning and managing health-related activities at the village level. The VHPMC is composed of representatives from the community, health workers, and local officials, and is responsible for identifying health needs, developing plans to address those needs, and monitoring the implementation of those plans.\n\n", "output3": "\n<bot>: Under National Health Mission, the Panchayat Health Committee (PHC) is responsible for planning and managing health-related activities at the village level. The PHC is a statutory body constituted by the Gram Panchayat, and its members include representatives from the village community, the Gram Panchayat, and the health department. The PHC is responsible for identifying the health needs of the village, developing and implementing health plans, and monitoring the implementation of health programs.\n\n", "output4": "\n<bot>: RogiKalyan Samiti is responsible for planning and managing health-related activities at the village level under the National Health Mission. The other options are not correct.\n\n"}]